SK BIOSCIENCE Stock Price & Chart

KRX: 302440 · SK바이오사이언스 · KOSPI

₩37,250▼ ₩750 (-1.97%)at close · September 11, 2026
61,30031,80037,250Aug 20, 25Nov 26Mar 06Jun 10Sep 11, 26

SK BIOSCIENCE (SK바이오사이언스, KRX: 302440) last closed at ₩37,250 on September 11, 2026, a -1.97% move on the day. Over the trailing 52 weeks the stock has traded between ₩31,800 and ₩61,300, a -19.63% change over the past year. Figures are end-of-day closing prices from the Korea Exchange.

Last close₩37,250
Day change-1.97%
52-week high₩61,300
52-week low₩31,800

Key Fundamentals

FY 2026.06
Market cap₩2.92T
P/E (PER)-50.82
P/B (PBR)1.63
EPS₩-733
BPS₩22,806
ROE-4.79%
Debt ratio48.58%
Rev. growth2.50%

P/E, P/B and market cap are computed from the latest close; EPS, BPS, ROE and debt ratio are the most recent reported figures (FY 2026.06) from the Korea Investment & Securities Open API. Informational only, not investment advice.

Technical Snapshot

as of 2026-09-11
Weak BearishAlgorithmic summary of 5 standard indicators (net score -1). Describes current technical posture only — not a buy or sell recommendation.
  • ▼ Bearish20-day MAPrice below 37,615
  • ▲ Bullish60-day MAPrice above 36,424
  • ▼ Bearish120-day MAPrice below 39,149
  • ▲ BullishMA trend (20 vs 60)Short-term above mid-term
  • · NeutralRSI (14)RSI 43 — neutral zone
  • ▼ BearishMACD (12,26,9)MACD below signal
52-week position: 18% of rangeRSI(14): 435-day volume vs 20-day: -21%

Indicators are computed mechanically from end-of-day prices. They are provided for informational purposes only, are not investment advice or a recommendation, and past performance does not indicate future results.

Reports mentioning SK BIOSCIENCE

No daily reports have covered SK BIOSCIENCE yet. New reports appear here automatically when the stock is featured.

← Back to all Korean stocks

Price history is sourced from the Korea Exchange via the Korea Investment & Securities Open API and updated after each trading session. This page is provided for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data may be delayed or contain errors — verify with an official source before trading.